✦ LIBER ✦

A comparison between 4 GM/M2 and 7 GM/M2 cyclophosphamide for peripheral blood stem cell mobilization

✍ Scribed by L. B. To; D. N. Haylock; P. G. Dyson; T. P. Rawling; J. L. Bayly; C. M. Rawling; A. N. Canty; B. Wake; D. Thorp; C. A. Juttner

Book ID: 112212388
Publisher: AlphaMed Press
Year: 1992
Tongue: English
Weight: 68 KB
Volume: 10
Category: Article
ISSN: 1066-5099
DOI: 10.1002/stem.5530100712

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensified-dose (4 gm/m2) cyclophospham

Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis

✍ Maxime Breban; Maxime Dougados; Françoise Picard; Simona Zompi; Jean-Pierre Maro 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

CFU-GM Capacity, Engraftment, and Long-T

CFU-GM Capacity, Engraftment, and Long-Term Graft Function: A Comparison of Three Methods of Peripheral Blood Hematopoietic Stem Cell Mobilization (G-CSF, G-CSF + Plerixafor, or Cyclophosphamide + G/GM-CSF) in Patients Receiving Similar CD34+ Cell Doses

✍ E.T. Alexander; J.A. Towery; J.E. Squires; C. Kramer; R.K. Stuart; L.J. Costa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Low doses of GM-CSF (molgramostim) and G

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients

✍ Quittet, P; Ceballos, P; Lopez, E; Lu, Z Y; Latry, P; Becht, C; Legouffe, E; Feg 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 180 KB

Mobilization of peripheral blood stem ce

Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CY

✍ Weaver, C H; Schwartzberg, L S; Zhen, B; Franco, C; Moore, M; Jr, R Smith; White 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB

Beyond CD34+ cell dose: impact of method

Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte–colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit–GM, engraftment, and Day +100 hematopoietic graft function

✍ Erin T. Alexander; Jeanne A. Towery; Ashley N. Miller; Cindy Kramer; Kathy R. Ho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 212 KB

P-C4-32 Comparison of young and old red

P-C4-32 Comparison of young and old red blood cell deformability for normal and diabetic blood: C. Zeitoun1, C. Bucherer1, C. Lacombe1, J.C. Lelievre1. M. Fonfrede2 and A. Grimaldi3 1 Unité de Biorhéologie, CHU Pitié-Salpêtrière, 75013, Paris, France 2 Laboratoire de Biochimie, Hôpital de la Salpêtrière, 75013, Paris, France 3 Service de Diabétologie, Hôpital Pitié-Salpêtrière, 75013, Paris, France

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 129 KB